University of California San Francisco
Give to UCSF
Displaying 31 - 60 of 695
-
-
PCOS Symptoms Are Still Difficult for Doctors to Diagnose and Treat. Here’s Why.
-
The U.S. Supreme Court Weighs Mifepristone for Abortion Care
An upcoming Supreme Court ruling could put a stop to telehealth abortion services nationally, and limit access to mifepristone, one of two drugs commonly used in abortion care.
-
COVID Vaccines Are Safe for Pregnant Women and Babies
A first of its kind study finds that the COVID vaccine is safe to administer during pregnancy, causing no abnormal delays when the infants were tested at 12 months and again at 18 months.
-
How AI Can Help Spot Early Risk Factors for Alzheimer’s Disease
UCSF scientists found a way to predict Alzheimer’s disease up to seven years before symptoms appear by analyzing patient records with machine learning. Conditions that most influenced prediction of Alzheimer’s were high cholesterol and, for women, osteoporosis.
-
Telehealth is as Safe as a Visit to the Clinic for Abortion Pills
Medication abortion can be delivered safely and effectively through telemedicine, according to new research that comes as the U.S. Supreme Court is about to hear a case that could severely restrict access to one of the two pills that are used to induce abortions.
-
California’s First Latinx Surgeon General Emphasizes Power of Positive Childhood in UCSF Stop
California’s trailblazing surgeon general is using her platform to pave the way for improving the health of women, children and communities of color while inspiring a new generation of Latinx physicians.
-
Research Can Help to Protect Access to Abortion, Biden Secretary Says
U.S. Health and Human Services Secretary Xavier Becerra visited UCSF Pride Hall at Zuckerberg San Francisco General Hospital to laud UCSF researchers, educators and clinical leaders for their leadership in reproductive health, as the Biden Administration seeks to preserve access to abortion care in post-Roe America.
-
Genetic Discovery Reveals Who Can Benefit from Preterm Birth Therapy
In a first, scientists at UCSF and Stanford identified genetic variants that predict whether a patient is likely to respond to treatment for preterm birth. Screening for mutations could allow doctors to target medications to those most likely to benefit. No medication is currently available in the U.S. to treat preterm birth.
-
Health Equity Leader to Chair UCSF Obstetrics and Gynecology
Andrea V. Jackson, MD, MAS, a highly regarded obstetrician, gynecologist and diversity champion, has been appointed chair of the UCSF Department of Obstetrics, Gynecology & Reproductive Sciences.
-
Why Do Young Women with Multiple Sclerosis Face Health Disparities?
Young Black and Hispanic women with multiple sclerosis fare worse than young white women with the disease. Minority women were more likely to have more advanced disease and faced greater challenges in pregnancy.
-
Amber Bell, MS ’19, CNM: Returning an Age-Old Vocation to its Roots
Amber Bell, MS ’19, CNM, is helping UCSF “do the hard work of re-diversifying the midwifery profession.”
-
Younger Women Who Have Never Smoked Are at Increasing Risk of Lung Cancer, Research Shows
-
Breast Cancer Treatments Offer More Options Than Surgery
-
Breast Cancer Riddle: Best Ways to Screen and Treat
Laura Esserman discusses breast cancer risk factors, progress in the field and the importance of tailoring treatment for women with low-risk cancer while also identifying women at high risk of invasive cancer.
-
Are New Therapies on the Horizon for Painful Skin Condition?
UCSF's HS PROGRESS study aims to understand and treat Hidradenitis Suppurativa, an often debilitating condition disproportionately affecting women and people of color.
-
Breast Cancer Screening Guidelines Should Evolve With Science
-
UCSF’s Diana Greene Foster Selected as a 2023 MacArthur Fellow
Diana Greene Foster, leader of a groundbreaking study on what happens to women who are denied abortions, has been named a 2023 MacArthur Fellow, one of the most coveted honors in academia, science and the arts.
-
The Growing Case for Doing Less: How Harmless Cancers Are Being Overdiagnosed in America
-
Will a Pill Help New Moms Bounce Back from Postpartum Depression?
Zuranolone (Zurzuvae), the first pill for patients suffering from postpartum depression, is expected to be available by the end of 2023. Though it may relieve depressive symptoms, it has some drawbacks such as sedation and dangers in breastfeeding.
-
Study Finds Significant Chemical Exposures in Women With Cancer
Researchers have found that people who developed breast, ovary, skin and uterine cancers have significantly higher levels of endocrine-disrupting chemicals in their bodies.
-
Protect Yourself and Loved Ones with the New RSV Vaccines
The FDA recently approved the world’s first vaccines to prevent RSV for infants and elderly adults.
-
UCSF Medical Center Is Among Nation’s Top Hospitals for 2023-24
UCSF Medical Center has been ranked among the country’s best hospitals in adult care in U.S. News & World Report’s prestigious Best Hospitals survey.
-
What Women Endure
-
How California Is Helping Save the Next Generation of Abortion Doctors
-
Breast Density and BMI Both Play a Role in Breast Cancer Risk
Laws in many states require notifying women if they have dense breasts, a risk factor for breast cancer. But density shouldn’t be the only factor in determining whether supplemental screening is
-
Doctors Test Chest Pain Medication to Treat Hot Flashes
UCSF researchers tested nitroglycerin patches, an treatment for chest pain from coronary artery disease, for menopausal hot flashes. Short-term benefits were seen, but not long-term as some side effects occurred.
-
UCSF Health Cancer Experts Featured at Premier Cancer Meeting
Oncology specialists from around the globe will gather for the American Society of Clinical Oncology (ASCO) Annual Meeting to discuss the latest cancer therapies, technologies, research and education.
-
How COVID Stay-At-Home Orders Helped Breastfeeding Mothers and Babies
-
Breastfeeding Increased by 2 Weeks When Mothers Stayed Home
Breastfeeding duration increased for U.S. women who were able to work from home during COVID, suggesting that a lack of paid family leave policies is a barrier to longer breastfeeding in the US.
